Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial-Reference-Cited by-同舟云学术

Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial

Published:2020-12-13 Issue:2 Volume:23 Page:609-618
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bae Jaehyun¹^ORCID,Huh Ji Hye²³,Lee Minyoung⁴^ORCID,Lee Yong‐Ho⁴^ORCID,Lee Byung‐Wan⁴^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine Catholic Kwandong University College of Medicine, International St. Mary's Hospital Incheon Republic of Korea

2. Division of Endocrinology and Metabolism, Department of Internal Medicine Hallym University Sacred Heart Hospital Anyang Republic of Korea

3. Division of Endocrinology and Metabolism, Department of Internal Medicine Yonsei University Wonju College of Medicine Wonju Republic of Korea

4. Division of Endocrinology and Metabolism, Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14259

Reference26 articles.

1. Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

2. Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status